Antibodies, Neutralizing

AUG 4, 2026 · JOURNAL ARTICLE

Comparative immunogenicity of mRNA-1273 and BNT162b2 SARS-CoV-2 bivalent booster vaccines in US nursing home residents.

Human Vaccines & Immunotherapeutics

A sound comparative immunogenicity study in a vulnerable population showing equivalent responses between two widely used vaccines, but limited by cross-sectional design, surrogate endpoints, and lack of clinical outcome data.

AUG 4, 2026 · JOURNAL ARTICLE

Advancing human metapneumovirus vaccine development through fusion protein stabilization.

Virology

This is a narrative review synthesizing structure-guided protein engineering strategies and preclinical immunogenicity data, raising mechanistic questions about pre-F stabilization rather than reporting a definitive clinical or confirmatory experimental result.

JUL 9, 2026 · JOURNAL ARTICLE

T cell-associated immunity induced by heterologous recombinant BCG and purified protein vaccination confers cross-variant protection against SARS-CoV-2.

Human Vaccines & Immunotherapeutics

A mechanistic study using genetically modified mouse models demonstrating that T cell-associated immunity from a heterologous rBCG/protein vaccine confers cross-variant protection against SARS-CoV-2 JN.1, with clear immunological endpoints but limited to preclinical animal models.